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Background. Most safety issues in primary care arise from adverse drug events. Team Resource Management intervention was
developed to identify systemic safety issues to design and implement interventions to address prioritized issues. Objectives.
Evaluate impact of intervention on rates of events and preventable events in a vulnerable population. Design. Cluster randomized
trial. 12 practices randomly assigned to either: (1) Intervention; (2) Intervention with Practice Enhancement Assistants; (3) No
intervention. The intervention took 12 months. Main Outcome Measure. Rate and severity of events and preventable events
measured using a Trigger Tool chart review method for the 12-month periods before and after the start of the intervention. Results.
In the “intervention with Assistants” group there was a statistically signiﬁcant decrease in the overall rate of events and in the rate
of moderate/severe events. Analysis of Variance with study arm and time as the factors and moderate/severe events as the outcome
showed a signiﬁcant interaction between arm and time supporting the notion that the “Intervention with Assistants” practices had
a greater reduction in moderate/severe preventable events. Conclusions. The intervention had a signiﬁcant eﬀect on medication
safety as estimated using a trigger tool. Further exploration of role of Assistants and trigger tool is warranted.
1.Introduction
Medication use is recognized to be a high-risk activity across
all settings. A recent Institute of Medicine (IOM) report
on this subject acknowledges that the rates and impact of
medication errors are huge but are poorly understood [1].
The President of the Institute of Safe Medication Practices
(ISMP), Michael Cohen [2], in his testimony to a committee
of the US Congress estimated that the dollar cost of adverse
drug events was about $200 billion across all settings.
In ambulatory settings, medication errors and adverse
drug events (ADEs) are one of the most important safety
issues. A study based on the National Ambulatory Medical
Care Survey (NAMCS) found that oﬃce-based physicians
prescribed at least 1 inappropriate medication to nearly
8% of the elderly who received prescriptions [3]. Another
study of ambulatory elderly patients with polymorbidity and
associated polypharmacy documented that 35% reported
experiencing at least one ADE within the previous year [4].
Gurwitz and colleagues have estimated (by extrapolation)
that Medicare enrollees alone suﬀer approximately 500,000
preventable ADEs per year [5].
A 2003 report of a multidisciplinary group (composed of
the AHRQ-supported Medical Group Management Associa-
tion Center for Research, the Centers for Medicare and Med-
icaid Services, and the Partnership for Patient Safety) draws
attention to the fact that while safety risks are widespread
in ambulatory settings, there has been insuﬃcient attention
paid to them [6]. Some estimates suggest that ambulatory
settings are at least equally important as inpatient settings,
with up to 200,000 avoidable deaths annually in the United
States of America (USA) alone [7, 8].
Lack of awareness of the type, the incidence, and conse-
quences of errors in any setting is one of the most important
barriers to reducing these errors and improving quality of2 International Journal of Family Medicine
care. The most commonly used method for estimating vul-
nerabilitiesinhealthcareistoretrospectively collectandcount
errors through voluntary reporting systems (often referred
to as “incident reports”). These are fraught with diﬃculty
due to underreporting (according to IOM’s 1999 report,
only 5% of known errors are typically reported—and then
there are unknown errors) and abuse (e.g., reports ﬁled and
counterﬁled as a means of retaliation against colleagues [9]).
Error reporting often does not promote understanding of
the organizational structure and processes of care. Instead it
tends to be associated with blame and shame, and frequently
results in antagonism between team members undermining
mutual respect, trust, and cooperation. The Patient Safety
and Quality Improvement Act (2005) was introduced in
large part to stimulate increased error reporting through
the creation of Patient Safety Organizations (PSOs). Bates
and colleagues have described diﬃculties involved in deﬁn-
ing and quantifying errors; they report that even direct
observational studies, which are highly labor intensive, often
miss errors [10]. An alternative approach that is prospective,
rather than retrospective, and encourages involvement of
all teammembers for identifying and prioritizing safety and
quality problems invokes Failure Modes and Eﬀects Analysis
(FMEA). This has been widely used in other high-risk
industries and has been advocated by the IOM9 as a means
of analyzing a system to identify its weaknesses (“Failure
Modes”), possible consequences of failure (“Eﬀects”), and
to prioritize areas for improvement. We have adapted and
tailored this methodology to allow for the levels of resources
andexpertiseavailableinambulatorysettings,anddeveloped
aninstrumentthathasbeenshown tobe eﬀectiveinavariety
of these settings. The details of the rationale and processes
behind this instrument termed “Safety Enhancement and
Monitoring Instrument that is Patient Centered” (SEMI-P)
are described elsewhere [11–15].
It is important to recognize, as Crabtree et al. [16]
have done, that a vital step toward creating the Medical
Home is to close the physician staﬀ divide so as to maintain
communication and coordination. They draw attention
to the fact that currently practice meetings are “univer-
sally unpopular” despite their indispensability. Our TRM
methodology, invoking the paradigm of complex adaptive
systems, is designed to aid formation of central “attractors”
in the form of self-empowered eﬀective learning teams with
a common vision to help their complex microsystems to
adapt and thrive [17–21]; thriving systems are endowed
with simple rules, shared vision, and opportunities for team
members to innovate.
An outcome-oriented team has to be enabled to (a)
own and identify vulnerabilities in their settings, (b) design
and implement interventions tailored for its settings, (c)
monitor the eﬃcacy of these interventions, and (d) con-
tinue the never ending journey in pursuit of safe care,
that is, continuing quality improvement. Interestingly, a
recent study by Quinn et al. [22] found that physicians
from practices that were involved in evaluation of quality
improvement activities had signiﬁcantly less isolation, stress,
and dissatisfaction.
Objective. T h ep r i m a r yo b j e c t i v eo ft h i ss t u d yw a st oe v a l u -
ate the impact of the prospective team resource management
methodology (TRM), based on the SEMI-P instrument,
(with and without the use of a practice enhancement
associate (PEA)) on
(a) the number of preventable ADEs in a vulnerable
population aged 65 and above;
(b) the severity of these preventable ADEs.
2. Methods
2.1. Study Design. This was a cluster randomized trial in
which 12 practices in the Upstate New York Practice-based
ResearchNetworkwereeachrandomized tooneof3states(4
practices each): (1) team resource management intervention;
(2) team resource management intervention with PEA;
(3) no intervention (comparison group). Randomization
was performed by an independent party, with concealed
allocation.
2.2. Intervention. This team-based approach has four stages.
These can be repeated to make a cycle, as shown in Figure 1,
for continuous quality and safety improvement.
2.3. Stage 1: Safety Enhancement and Monitoring Instrument
That Is Patient Centered (SEMI-P)—Duration: 1 Month.
This anonymous survey is an opportunity for all staﬀ to
freely express opinions about the care processes in their
setting. This survey asks about each of the steps in the
medication use process. To help orient staﬀ to the overall
process, the survey uses a diagram (Figure 2) that shows who
and what is involved in the processes and how they work (or
are supposed to work) together.
Errorscanoccuratanypointintheprocessdiagram.The
survey looks at all the main areas in the process. Each page of
the survey is about a diﬀerent area and consists of a list of
errors or causes of error that can occur in that area. The lists
are based on review of the literature and consultation with
practicing physicians and nursing leaders. The survey asks
staﬀtothinkabouteachoftheerrorsinturnand,foreach,to
indicate their opinion about how often it occurs and, when it
does happen, how severe the consequences usually are. The
bottom of each page provides an explanation of the various
options. The diagram of the testing process is included on
each page, with red highlighting to show which part of the
process is being asked about. Everyone who works in the
practice is asked to complete the survey anonymously. If
willing, they can mark their job category (provider, nursing,
or administrative). The respondents took an average of 20
minutes to complete the survey.
2.4. Stage 2: Identiﬁcation of Most Hazardous Problems in
the Testing Process, and Choosing Priorities—Duration: 1
to 2 Months. Scores (called Hazard scores obtained by
multiplying frequency of each error with its respective
severity of consequence) are calculated for each error in the
survey, based on respondents’ answers to the frequency andInternational Journal of Family Medicine 3
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Figure 1: Cyclical Approach to Monitoring and Enhancing Patient Safety.
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Figure 2: Micromodel of a Medication management in the Ambulatory Setting.
severity questions. The items are then listed in rank order
(highest to lowest) and presented to staﬀ in a graphical
format in a group meeting for their discussion. This helps
the team to form a common vision and consensus regarding
which problems need to be addressed ﬁrst.
2.5. Stage 3: Development of Solutions—Duration: 2 to 3
Months. In further group meetings, staﬀ discuss the pri-
oritized problems and work together to design solutions,
keeping in mind the resources available and the capabilities
of their unique setting.4 International Journal of Family Medicine
Table 1: Characteristics of the study sites.
Site
Characteristic
Arm 1 Arm 2 Arm 3
Site 1A Site 1B Site 1C Site 2A Site 2B Site 2C Site 2D Site 3A Site 3B Site 3C Site 3D
Ownership Hospital
(satellite)
Hospital
(satellite) Private Hospital
(satellite) Private Private Hospital
(onsite) Private Hospital
(onsite)
Hospital
(onsite) Private
Geographic
location Urban Urban Urban Urban Urban Rural Urban Urban Urban Urban Urban
Residency
practice site?
(Y/N)
YYN Y N N N N Y N Y
Approximate
visits per year 13,780 9,300 37,800 25,000 23,000 5,000 5,000 60,000 18,000 4,500 13,000
Total Staﬀ 45 36 60 40 20 3 20 45 82 12 30
2.6. Stage 4: Implementation and Tracking of the Solutions—
Duration: 6 to 8 Months. Teams are formed to implement
the solutions, with clear allocation of responsibilities and
an agreed time schedule. Solutions are revised based on
experience.
All staﬀ at the intervention sites were invited and
encouraged to participate. The total intervention period was
12 months.
2.7.RoleofthePEA. OnePEAwasassignedtoworkwithall4
practices in this group. She had completed a Master’s degree
in nutrition but with no prior experience working with
practices. She participated in all study-related team meetings
at each practice and made herself available to each practice
for up to half a day a week throughout the study period
to support safety and quality improvement activities (not
limited to study-related activities). The main contribution of
the PEA was to follow through on plans developed by the
practice team, that is to support Stages 3 and 4 in the TRM
cycle outlined above. Examples of PEA activities include
developing patient education materials, preparing draft
protocols, and collecting resources for patient prescription
assistance.
2.8. Outcome Measure. The rate and severity of ADEs and
preventable ADEs were measured by chart review for the
two 12-month periods before and after the start of the
intervention. Eligible patients were those aged 65 years and
above, who had at least one visit for cardiovascular disease
(ICD-9-CM codes 390–459) during the measurement period
and at least one visit for any diagnosis in the prior year.
If there were 200 or fewer eligible charts at a site, all were
screened, otherwise a random sample of 200 was taken.
The chart review was performed using a Trigger Tool
method that involves 2 steps, namely a screening step
and a review step [5, 23–32]. The screening step involves
identifying the presence of certain chart ﬁndings, known
as triggers, that are known to be possible evidence of an
adverse event. In this study, the triggers of interest are
those that might represent an adverse drug event (ADE).
Examples include an elevated INR (often associated with
adverse eﬀects of warfarin) and abrupt discontinuation of a
medication (that sometimes occurs because of an ADE). In
our study research assistants performed the screening step,
using a previously published ADE trigger tool [23] that we
adapted from the work of others [5, 25, 26]. In the second
step, known as the review step, a physician and pharmacist
reviewed the identiﬁed triggers to determine for each trigger:
(1) whether an ADE took place and if so, (2) whether the
event was preventable, (3) the stage of the medication use
process where the ADE originated (prescribing, dispensing,
administration, and monitoring), and (4) the eﬀect on
the patient (none/minimal, mild, moderate, or severe).
Examplesofpreventableerrorsincludemissedallergy,wrong
dosage, errors of dispensing, administration errors, and
failure to order or complete laboratory monitoring.
The physician and pharmacist worked together, review-
ing, discussing, and recording their consensus opinion of
each trigger. When they were unable to reach consensus
a ﬁnal determination was made by a third reviewer. If
they identiﬁed any potential or actual harm that had not
been previously recognized and addressed, they notiﬁed the
primary care physician or site medical director. Triggers that
were deemed to represent the same ADE were excluded to
avoid “double counting” an ADE.
The study protocol was approved by the Social and
Behavioral Sciences Institutional Review Board of the State
University of New York at Buﬀalo.
3. Results
Part way into the study, one of the Comparison group
practices withdrew from the study, citing concerns over the
administrative burden of the chart reviews (the practice
was undergoing administrative changes). Table 1 shows the
characteristics of the 11 sites that completed the study.
At baseline, 1970 charts (mean 179 per site) were
screened. Of these, 1066 (54.1%) had triggers, yielding a
total of 2898 triggers. This far exceeded our expectation
and therefore posed a practical problem due to the eﬀort
(and therefore cost) associated with reviewing this number
of triggers. Therefore, we elected to reduce the sample
by randomly eliminating a proportion of patients at each
site, suﬃcient to reduce the number to approximately 100
patients per site. This yielded a total of 1125 patients, ofInternational Journal of Family Medicine 5
Table 2: Preventable adverse drug event rates (pADEs).
Comparison arm Intervention arm (unaided) Intervention arm (with PEA)
Severity of pADE Before (n = 253) After (n = 294) Before (n = 419) After (n = 390) Before (n = 453) After (n = 366)
All Severities 27 (10.7) 25 (8.5) 38 (9.1) 18 (4.6) 56 (12.4) 27 (7.4)∗
None/Minimal or Mild 18 (7.1) 12 (4.1) 27 (6.5) 15 (3.8) 27 (5.8) 21 (5.8)
Moderate or Severe 9 (3.6) 13 (4.4) 11 (2.6) 3 (0.8) 29 (6.4) 6 (1.6)∗∗
∗P = 0.018 by paired t-test (after versus before) at the site level.
∗∗P = 0.035 by paired t-test (after versus before) at the site level.
Values presented as number of pADEs (rate per 100 patient-yrs).
whom 598 patients had one or more triggers, all of which
underwent review. A similar process was used to make the
endpoint data manageable, yielding 1050 patients, of whom
564 had triggers that were reviewed.
Table 2 summarizes the rates of preventable ADEs (nor-
malized per 100 patient-years) for each arm of the study.
For each arm, we compared the pADE rate (per 100 patient-
years) at the two time points (After versus Before) by means
of a paired t test with sites as the unit of analysis. As
showninTable 2,inthe“InterventionwithPEA”groupthere
was a statistically signiﬁcant decrease in the overall rate of
pADEs after the intervention compared to before (7.4 per
100 patient-years versus 12.6, P = 0.018) and in the rate of
moderate or severe (combined) pADEs(1.6 versus 6.4, P =
0.035).IntheComparisonarmandtheunaidedIntervention
arms, there were no statistically signiﬁcant diﬀerences over
time.
Analysis of Variance (ANOVA) with study arm and time
as the factors and total pADEs as the outcome variable
showednosigniﬁcantinteractionbetweenarmandtime. For
the outcome of moderate or severe pADEs, the interaction
term was signiﬁcant (P = 0.023) supporting the notion that
the“InterventionwithPEA”practiceshadagreaterreduction
in moderate/severe pADEs over time than the comparison
group.
4. Discussion
The TRM approach, when aided by a PEA, demonstrated
a signiﬁcant reduction in pADEs, especially those with
the highest severity. The reduction in pADEs represents
a signiﬁcant improvement in patient safety through the
collective eﬀorts of practice staﬀ guidedby astructuredTRM
process.
Itappearsthattheadditionalresourceoﬀeredintheform
of a PEA was important, as the non-PEA practices did not
achieve the same statistically signiﬁcant improvement that
the PEA practices did. While the “mechanism of action”
of the PEA is not clearly understood, it is reasonable
to surmise that the extra human resource represented by
the PEA enabled practices to more eﬀectively implement
their planned interventions. Practices may generally have
diﬃculty following through on plans because of existing
high workloads. The addition of a PEA may have helped to
minimize the incremental burden on teams that are already
overburdened.
While we did not formally evaluate this, it is the
authors’ observation that the humanistic self-empowerment
approach used in this study helped to energize front-
line workers to maintain and continually improve quality.
Staﬀ commented that seeing other people’s perspectives
(as reﬂected in SEMI-P results) helped to improve mutual
understanding,leadingtoconsensus.Further,webelievethat
by closing the physician staﬀ divide, and encouraging closer
communicationandcoordinationbetweenteammembersin
addressing practice issues, the TRM approach can achieve
progress toward the creation of the Medical Home [16].
The study was a pilot study and has various limita-
tions. Firstly, the outcome measure is based on a trigger
tool methodology that has limited sensitivity. In fact, the
sensitivity of the trigger tool is unknown because there is no
gold standard against which to compare it. This means that
the rates of pADEs reported should not be seen as estimates
of true rates. Instead, they represent only a subset of pADEs,
thatis,thosethatareidentiﬁablebythetriggertool.However
there is no reason to expect that the sensitivity of the trigger
tool would vary between study groups or over time so the
validity of the study ﬁndings is not jeopardized. Another
signiﬁcant weakness is the small size of the study. Having
only 3-4 practices in each arm limited the power. A larger
study including a greater number of practices is warranted.
In addition, further exploration of the role of the PEA is
required to establish the most important “active ingredients”
so that these can be deployed in an eﬃcient way.
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